CNMD, US2074101013

CONMED stock gains 2.22 percent ahead of October 28 results

Published on 10/05/2026 at 20:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

CONMED stock was trading at USD 47.35 on October 5, 2026, while Q2 revenue reached USD 343.49 million. EPS came in at USD 1.38 against USD 1.11 consensus.

CNMD, US2074101013, Illustration mit AI erstellt.

CONMED stock (ISIN US2074101013) was trading at USD 47.35 on the NYSE on October 5, 2026, up USD 1.03 or 2.22 percent from the prior close. The medical-device maker has scheduled its third-quarter results for October 28, giving investors a defined checkpoint after a better-than-expected second quarter.

October 28 is the next checkpoint

According to CONMED in a release dated October 1, 2026, the company will publish third-quarter results after the market close on October 28, 2026. Management will discuss the figures during a conference call at 4:30 p.m. ET on the same date.

The scheduled report matters because the second quarter combined modest sales growth with stronger earnings. MarketBeat reported that Q2 revenue reached USD 343.49 million, up 0.3 percent year over year, while EPS came in at USD 1.38 versus the USD 1.11 consensus estimate.

Profitability carries the story

Simply Wall St described the latest quarter as a case of flat revenue alongside stronger profitability and higher full-year EPS guidance. That combination places more weight on margins, product mix and execution than on rapid top-line expansion.

CONMED's 2026 full-year guidance cited by MarketBeat stands at USD 4.48 to USD 4.60 in EPS. The range gives the October report a clear test: whether earnings momentum can continue while revenue growth remains limited.

Analysts remain cautious

MarketBeat said on September 14, 2026, that eight analysts carried an average Reduce rating, including two sells and six holds. Their average 12-month price target was USD 41.40, below the USD 46.15 share price cited in that report.

That consensus is more cautious than the October 5 trading move. The stock's current USD 47.35 price is also below its USD 53.66 52-week high, leaving the October 28 results as the next quantified test for the earnings-led narrative.

CONMED stock trades higher before results

CONMED stock was trading at USD 47.35 on the NYSE at 2:32 p.m. ET on October 5, 2026, with a session range of USD 46.02 to USD 47.62. Its market capitalization was USD 1.4 billion.